Back to Newsroom

ProMIS™ Neurosciences Provides Third Quarter Update for 2017

TORONTO, Ontario and CAMBRIDGE, Massachusetts – October 11, 2017 – ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today provided a corporate update for the third quarter of 2017, including key accomplishments and a status update on ongoing programs.